Vanda Pharmaceuticals
VNDA
VNDA
157 hedge funds and large institutions have $222M invested in Vanda Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less funds holding
Funds holding: 179 → 157 (-22)
45% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 47
Holders
157
Holding in Top 10
–
Calls
$211K
Puts
$88K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$6.7M | |
| 3 | +$2.16M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.96M |
| 5 |
Renaissance Technologies
New York
|
+$1.75M |
Top Sellers
| 1 | -$5.11M | |
| 2 | -$4.29M | |
| 3 | -$2.06M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.6M |
| 5 |
KAM
Krensavage Asset Management
New York
|
-$1.56M |